Clinical Trial Update: Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

View source ↗

Summary

A completed real-life surveillance study of chronic hepatitis C patients treated with PegIntron and Rebetol (Study P04538) is reported, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Status: COMPLETED | Results posted: 2011-01-10